Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Robson

Showing results (101-110 of 210) with videos related to

Pageof 21
Sort By:
The Journal of Pathology|July 4, 2007
Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancerK Sahadevan, S Darby, H Y Leung, et al.
Oncogene|July 12, 2023
Engineering prostate cancer in vitro: what does it take?Adriana Buskin, Emma Scott, Ryan Nelson, et al.
Nucleic Acids Research|December 10, 2014
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancerMark A Wade, Dominic Jones, Laura Wilson, et al.
Physical Chemistry Chemical Physics : PCCP|August 5, 2015
Solid-state NMR as a probe of anion binding: molecular dynamics and associations in a [5]polynorbornane bisurea host complexed with terephthalateAditya Rawal, James M Hook, Ryan N Robson, et al.
Cancer Research|October 23, 1997
Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissueF C Hamdy, P Autzen, M C Robinson, et al.
British Journal of Cancer|June 5, 2003
FGF8 isoform b expression in human prostate cancerV J Gnanapragasam, M C Robinson, C Marsh, et al.
British Journal of Cancer|September 29, 2011
Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancerK Armstrong, I Ahmad, G Kalna, et al.
Oncogene|August 28, 1997
Keratinocyte growth factor expression in hormone insensitive prostate cancerH Y Leung, P Mehta, L B Gray, et al.
The Journal of Pathology|April 9, 2005
Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancerV J Gnanapragasam, S Darby, M M Khan, et al.
The Prostate|November 27, 1998
Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferationM I Johnson, M C Robinson, C Marsh, et al.
Pageof 21

Showing results (101-110 of 210) with videos related to

Sort By:
Pageof 21
The Journal of Pathology|July 4, 2007
Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancerK Sahadevan, S Darby, H Y Leung, et al.
Oncogene|July 12, 2023
Engineering prostate cancer in vitro: what does it take?Adriana Buskin, Emma Scott, Ryan Nelson, et al.
Nucleic Acids Research|December 10, 2014
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancerMark A Wade, Dominic Jones, Laura Wilson, et al.
Physical Chemistry Chemical Physics : PCCP|August 5, 2015
Solid-state NMR as a probe of anion binding: molecular dynamics and associations in a [5]polynorbornane bisurea host complexed with terephthalateAditya Rawal, James M Hook, Ryan N Robson, et al.
Cancer Research|October 23, 1997
Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissueF C Hamdy, P Autzen, M C Robinson, et al.
British Journal of Cancer|June 5, 2003
FGF8 isoform b expression in human prostate cancerV J Gnanapragasam, M C Robinson, C Marsh, et al.
British Journal of Cancer|September 29, 2011
Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancerK Armstrong, I Ahmad, G Kalna, et al.
Oncogene|August 28, 1997
Keratinocyte growth factor expression in hormone insensitive prostate cancerH Y Leung, P Mehta, L B Gray, et al.
The Journal of Pathology|April 9, 2005
Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancerV J Gnanapragasam, S Darby, M M Khan, et al.
The Prostate|November 27, 1998
Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferationM I Johnson, M C Robinson, C Marsh, et al.
Pageof 21